Equity Overview
Price & Market Data
Price: $3.88
Daily Change: $0.00 / 0.00%
Daily Range: $3.74 - $3.97
Market Cap: $272,669,760
Daily Volume: 618,038
Performance Metrics
1 Week: 1.31%
1 Month: -1.27%
3 Months: 3.74%
6 Months: 95.96%
1 Year: 210.4%
YTD: 3.74%
Company Details
Employees: 86
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.